Descriptor English: | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | ||||||
Descriptor Spanish: |
Combinación Elvitegravir, Cobicistat, Emtricitabina y Fumarato de Tenofovir Disoproxil
| ||||||
Descriptor Portuguese: | Combinação Elvitegravir, Cobicistat, Emtricitabina e Fumarato de Tenofovir Desoproxila | ||||||
Descriptor French: | Association d'elvitégravir, de cobicistat, d'emtricitabine et de fumarate de ténofovir disoproxil | ||||||
Entry term(s): |
Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination Genvoya Pill, Quad Quad Pill Stribild |
||||||
Tree number(s): |
D02.241.081.251.203.500 D02.705.429.906.250 D02.886.675.182.500 D03.383.129.708.189.500 D03.383.742.680.245.500.600.250 D03.633.100.759.138.881.250 D13.570.230.329.525.250 D13.570.685.245.500.600.250 D26.310.391 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069545 | ||||||
Scope note: | A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-HIV Agents |
||||||
Public MeSH Note: | 2016; ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE was indexed under CARBAMATES; DEOXYCITIDINE; THIAZOLES; QUINOLONES and ORGANOPHOSPHONATES 2012-2015 |
||||||
History Note: | 2016 (2012) |
||||||
DeCS ID: | 55887 | ||||||
Unique ID: | D000069545 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2016/01/01 | ||||||
Date of Entry: | 2015/07/01 | ||||||
Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations
|
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Preferred
Stribild
- Narrower
Quad Pill
- Narrower
Genvoya
- Narrower
Concept UI |
M000606070 |
Scope note | A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS. |
Preferred term | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination |
Entry term(s) |
Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination |
Concept UI |
M0577312 |
Preferred term | Stribild |
Concept UI |
M000606071 |
Preferred term | Quad Pill |
Entry term(s) |
Pill, Quad |
Concept UI |
M000619337 |
Preferred term | Genvoya |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey